Search
  • Jill Forrest, President Oncology Strategies

Recognizing the patient in drug development: Is your company patient centric?


Clinical trials can benefit from patient involvement in the planning and development of new therapies at an early stage. Further, it is often more economical in terms of drug development time and financial investment to add patient-centered metrics to trial protocol at an early rather than late stage of development. From First Word "Pursuing the Patient Centric Model" - a free report.

Go to Firstword for copy of report.


32 views

info@oncologystrategies.com   |   Overland Park, KS 66223

  • Facebook Basic Black
  • Twitter Basic Black
  • Black Instagram Icon